Friedrich & ClementBETA

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Cinacalcet (excl. in standard package size N3), ATC H05BX01 for the period 01.11.26-31.10.28 (plus option for extension 1x12 months)

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cinacalcet (ausschl. in der Normgröße N3), ATC H05BX01 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)

Germany · Hamburg · how to bid here

Your path to submission

  1. Deadline: 5 September at 00:00 — 1083 days left.
  2. The submission point is stated in the notice (link on the right).
  3. Offer and evidence in: DEU.
  4. Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Compiled automatically from notice and documents — no guarantee; the procedure's wording is binding.

Clement What the numbers say about this buyer

  • The median procedure drew 9 bids (3,222 procedures with a bid count); 7% ended with a single bidder. Sector: median 2 bids.n = 3,222
  • In this sector the buyer awards roughly every month (2768 awards, most recently June 2026) — by that rhythm the next award was due around July 2026. The last award went to Sanofi-Aventis Deutschland GmbH.n = 2,768
  • 82% of this buyer's awards went to companies that had already won here before (3,227 awards since 2017, spread over 567 companies). That is well above the sector norm (62%) — newcomers have a harder time here than elsewhere.n = 3,227 awards since 2017
  • 83% of the bids received came from small and medium-sized enterprises (15 procedures with a bid mix). Sector: 39%.n = 15
  • The award came in at a median 79% of the estimated value (6 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 87%.n = 6

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 13/09/2026.

Clement
References and certificates from your home country count fully across the EU — that is what European procurement law is for.
Prequalify once (PQ register) instead of collecting certificates for every bid — worth it from a few offers per year.

Foreign bidders

In Germany · Medical equipment & pharma, 257 contracts went to foreign companies over the last 3 years (of 21,997 recorded awards) — mostly from Austria, Netherlands, France.

Typical field: median 11 (from 4,048 awards).

Measured from linked award data; foreign winners bidding through a local subsidiary count as domestic — the true share is higher.

What the buyer is looking for

The summary in English is being prepared. The official description below is in the original language (DE).

Show original description (DE)

§ 130a Absatz 8 SGB V ermöglicht den Krankenkassen und pharmazeutischen Unternehmen, Rahmenrabattverträge über die zu Lasten der gesetzlichen Krankenkassen abzugebenden Arzneimittel zuschließen. In Hinblick auf die dafür einschlägigen gesetzlichen Vorschriften zur Vergabe öffentlicher Aufträge, findet ein regelmäßiger Prozess wirkstoffbezogener, förmlicher Vergabeverfahren nach den Regularien des 4. Teils des GWB durch die DAK-Gesundheit statt. Für vom Bieter näher in der Anlage 2 zum Vertrag zu benennende Arzneimittel zu dem o. g. Wirkstoff Cinacalcet (ausschließlich in der Normgröße N3), ATC H05BX01, beabsichtigt die DAK-Gesundheit, bis zum Inkrafttreten neuer Arzneimittelrabattverträge mit möglichst allen interessierten pharmazeutischen Unternehmen Arzneimittelrabattverträge abzuschließen. Ein Rabattvertrag i.R.d. Zulassungsmodells zu dem o. g. Wirkstoff tritt erstmals am 01.11.2026 in Kraft und endet am 31.10.2028 (zzgl. Verlängerungsoption 1x12 Monate). Er endet unabhängig davon automatisch mit Inkrafttreten des Exklusivvertrages.

Description as published (DE).

Selection criteria — in the procurement documents

The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in DEU.

Eligibility analysis from the tender documents

Contract

BuyerDAK-Gesundheit
TypeSupplies
Estimated value1 €
Published17 September 2026
CategoryMedical equipment & pharma · CPV 33600000

Who has won here before

CompanyAwardsPeriod
Abacus Medicine A/S · Kopenhagen1822022–2026
kohlpharma GmbH · Merzig1652022–2026
EurimPharm Arzneimittel GmbH · Saaldorf-Surheim1312022–2026
CC Pharma GmbH · Densborn1282022–2025
Orifarm GmbH · Leverkusen1182015–2025
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.

How often this buyer tenders this

2019157
2020108
2021135
2022107
2023204
2024623
20259
20251,071
2026587

Who knows the rhythm prepares instead of reacting.

·
days until the deadlineWednesday 5 September at 00:00

How to bid

Guide: how to apply on cosinex Vergabemarktplatz / DTVP → Registration, signature, fees — from the operator's bidder manual.

Read the full noticeOriginal + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.

Tender documents — direct download

Specifications and annexes hosted by the buyer — usually accessible without registration.
Tenders like this, every morning at 7:30 in your inbox.
Register now →